Clinical trial

Role of Early Versus Late Switch to Lapatinib-Capecitabine

NCT01357863

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2010-07-15

PhaseN/A

Study timeline

Study start (unknown)2010-07-15Date precision: day

Registry last updated2018-09-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancerunresolved

Interventions

TreatmentDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

São PauloBrazil1 Porto AlegreRio Grande do Sul, Brazil1 Rio de JaneiroBrazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01357863 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.